Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $9.9900 (-1.96%) ($9.9500 - $10.3300) on Thu. Aug. 15, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.04% (three month average) | RSI | 16 | Latest Price | $9.9900(-1.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -2.6% a day on average for past five trading days. | Weekly Trend | FOLD declines -9.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(60%) XBI(56%) IWO(55%) IWM(52%) IWC(50%) | Factors Impacting FOLD price | FOLD will decline at least -1.52% in a week (0% probabilities). VIXM(-33%) VXX(-19%) TLT(-15%) IFRA(-10%) TIP(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.52% (StdDev 3.04%) | Hourly BBV | 0 () | Intraday Trend | -2.3% | | | |
|
1 - 5 Day Possible Target | $-4.57(-145.75%) | Resistance Level | $11.78 | 5 Day Moving Average | $10.37(-3.66%) | 10 Day Moving Average | $10.98(-9.02%) | 20 Day Moving Average | $11.78(-15.2%) | To recent high | -24.6% | To recent low | 0% | Market Cap | $2.58b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |